Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.
The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.
CURRENT THERAPIES IN EPISODIC MIGRAINE MANAGEMENT
Adina Roceanu and Ovidiu Bajenaru
Migraine is a common neurological disease characterized by severe, recurrent episodes of throbbing, unilateral, headache.
Non-pharmacologic migraine treatment refers to the patient behavioral modification in order to avoid trigger.
Current therapies in migraine attack treatment are non-specific drugs (non-steroidal anti-inflammatory drugs, aspirin, antiemetics) and specific antimigraine drugs (ergot alkaloids, serotonin 5-HT1B/1D receptor agonists – triptans).
For migraine prophylaxis are recommended beta-blockers (metoprolol, propranolol), calcium channel blockers (flunarizine), antiepileptic drugs (valproic acid, topiramate), antidepressants (amitriptilyne, fluoxetine).
Keywords: migraine, ergot alkaloids, triptans, antiepileptic drugs
Full text | PDF